title: Daily phosphodiesterase type 5 inhibitor therapy: a new treatment option for prostatitis/prostatodynia?
authors.forename: Roger S
authors.initials: RS
authors.lastname: Kirby
authors.forename: Culley
authors.initials: C
authors.lastname: Carson
authors.forename: Prokar
authors.initials: P
authors.lastname: Dasgupta
mesh_terms: D002243:Carbolines / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D008297:Male; D058986:Phosphodiesterase 5 Inhibitors / Q000008:administration & dosage*; D011472:Prostatitis / Q000188:drug therapy*; D000068581:Tadalafil; D016896:Treatment Outcome
chemical_list: D002243:Carbolines; D058986:Phosphodiesterase 5 Inhibitors; D000068581:Tadalafil